Granules India Acquires Swiss CDMO Senn Chemicals AG for ₹192 crore

Biosynth Acquires Pepceuticals to Add Multi-Kilogram GMP Peptide Manufacturing

September 25, 2023

Pharmaceuticals

Biosynth has acquired Pepceuticals, a UK-based specialist in synthetic peptides with multi-kilogram GMP and fill-finish capabilities. The deal expands Biosynth’s peptide division and enables end-to-end support from discovery through clinical trials to commercial supply.

Formosa Laboratories Acquires SynChem to Expand North American CDMO Footprint

June 3, 2024

Pharmaceuticals

Formosa Laboratories, Inc., a Taiwan-based API supplier and CDMO, has completed its acquisition of SynChem, Inc., a contract research laboratory in suburban Chicago. SynChem will operate as SynChem-Formosa with Dr. W. Paul Mar remaining as CEO as the combined operations expand Formosa's US CDMO capabilities for small-molecule APIs and ADC-related chemistries.

eMolecules Acquires Synple Chem AG

September 24, 2024

Biotechnology

eMolecules, a San Diego-based provider of a chemical compound search-and-fulfillment platform and a portfolio company of Avista Healthcare Partners, has acquired Synple Chem AG, an automated chemical synthesis systems and services provider headquartered near Zurich, Switzerland. The acquisition adds Synple's automation technology and a virtual compound library of more than 7 trillion tractable compounds to eMolecules' existing offering, expanding its capabilities as a one-stop shop for compound procurement, management and automation for drug discovery customers.

Advent International to Acquire Significant Stake in Suven Pharmaceuticals

December 26, 2022

Pharmaceuticals

Advent International has entered into a definitive agreement to acquire a significant stake in Suven Pharmaceuticals from the Jasti family and will make an open offer for an additional 26% of public shares. Advent plans to evaluate a merger of its CDMO and API platform company, Cohance Lifesciences, with Suven to create a scaled end-to-end CDMO + merchant API powerhouse serving pharma and specialty chemical markets, subject to board and regulatory approvals.

Astorg Acquires Pharmaceutical CDMO CordenPharma from ICIG

May 2, 2022

Pharmaceuticals

Astorg has signed a binding agreement to acquire CordenPharma, a global contract development and manufacturing organization (CDMO) focused on APIs, excipients and drug products, from International Chemical Investors Group (ICIG). CordenPharma employs over 2,600 people across 11 manufacturing sites and an R&D laboratory in Europe and the US; the founders will reinvest alongside Astorg. The transaction is subject to customary regulatory approvals and terms were not disclosed.

Calibre Scientific Acquires Chemos GmbH & Co. KG

May 16, 2023

Manufacturing

Calibre Scientific has acquired Chemos GmbH & Co. KG, a Germany-based supplier of ready-to-use laboratory chemicals, reagents, standards and production raw materials. The acquisition adds Chemos' sourcing, formulation and toll-manufacturing capabilities to Calibre's global life-science portfolio to expand product offerings and support customers across analytical, chemical, food and pharmaceutical end markets.